Cargando…
Chemotherapy in vivo against M109 murine lung carcinoma with cytochalasin B by localized, systemic, and liposomal administration
Cytochalasin B is a potentially novel microfilament-directed chemotherapeutic agent that prevents actin polymerization, thereby inhibiting cytokinesis. Although cytochalasin B has been extensively studied in vitro, only limited data are available to assess its in vivo potential. Cytochalasin B was a...
Autores principales: | Trendowski, Matthew, Mitchell, Joan M., Corsette, Christine M., Acquafondata, Christopher, Fondy, Thomas P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387252/ https://www.ncbi.nlm.nih.gov/pubmed/25560541 http://dx.doi.org/10.1007/s10637-014-0202-6 |
Ejemplares similares
-
Chemotherapy with cytochalasin congeners in vitro and in vivo against murine models
por: Trendowski, Matthew, et al.
Publicado: (2015) -
Preparation, In Vivo Administration, Dose-Limiting Toxicities, and Antineoplastic Activity of Cytochalasin B
por: Trendowski, Matthew, et al.
Publicado: (2015) -
Effects of cytochalasin congeners, microtubule-directed agents, and doxorubicin alone or in combination against human ovarian carcinoma cell lines in vitro
por: Trendowski, Matthew, et al.
Publicado: (2015) -
Effects of mTOR inhibitors and cytoskeletal-directed agents alone and in combination against normal and neoplastic hematopoietic cells in vitro
por: Trendowski, Matthew, et al.
Publicado: (2015) -
Using Cytochalasins to Improve Current Chemotherapeutic Approaches
por: Trendowski, Matthew
Publicado: (2015)